Only 30% of Autoimmune Patients Accept FND Diagnosis, With Poor Explanations Linked to Suicidal Distress

Researchers from University of East Anglia and Cambridge surveyed and interviewed participants to map diagnostic disagreements in Rheumatology. Patients reported symptoms dismissed as psychosomatic or FND despite objective autoimmune markers, while clinicians cited insufficient training and unclear etiology. Absolute agreement rates dropped further when explanations implied psychological causation, eroding trust and prompting guilt or suicidal ideation in multiple cases.

Stigma patterns mirror earlier observational data in The Lancet Neurology on FND underdiagnosis in systemic lupus and rheumatoid arthritis cohorts, where delayed multidisciplinary input correlated with higher emergency visits. The current study adds qualitative evidence that inconsistent communication amplifies harm beyond the 53% fibromyalgia agreement rate, highlighting how single-specialty care misses overlapping neurological-autoimmune mechanisms.

Analysis shows early diagnostic caution and joint rheumatology-neurology pathways could reduce misattribution in both directions. Future interventional trials must track validated trust and suicide-risk scales rather than surrogate acceptance metrics alone.

Next steps include piloting standardized explanation scripts and tracking 12-month outcomes in UK autoimmune clinics to test whether agreement rates rise above 50%.